11 Cathie Wood Twist Bioscience Trades
Cathie Wood acquired 6.27 Million Twist Bioscience shares worth $226 Million. That's 1.65% of their equity portfolio (21st largest holding). The investor owns 11.21% of the outstanding Twist Bioscience stock. The first Twist Bioscience trade was made in Q4 2019. Since then Cathie Wood bought shares seven more times and sold shares on three occasions. The investor's estimated purchase price is $434 Million, resulting in a loss of 48%.
Avg closing price
Price range
Increased shares by 19.1% (+1 Million shares)
Q2 2022
Avg closing price
$35.42
Price range
$26.20
-
$54.00
Increased shares by 39.7% (+1.5 Million shares)
Q1 2022
Avg closing price
$55.42
Price range
$38.58
-
$83.27
Sold 4.5% shares (-179 Thousand shares)
Q4 2021
Avg closing price
$102.64
Price range
$75.47
-
$135.88
Sold 21.9% shares (-1.11 Million shares)
Q3 2021
Avg closing price
$114.50
Price range
$95.64
-
$131.48
Sold 16.4% shares (-991 Thousand shares)
Q2 2021
Avg closing price
$116.25
Price range
$88.13
-
$142.06
Increased shares by 2.9% (+169 Thousand shares)
Q1 2021
Avg closing price
$151.85
Price range
$105.48
-
$207.97
Increased shares by 86.0% (+2.72 Million shares)
Q4 2020
Avg closing price
$110.94
Price range
$76.64
-
$167.89
Increased shares by 92.3% (+1.52 Million shares)
Q3 2020
Avg closing price
$62.26
Price range
$45.46
-
$78.79
Increased shares by 155.2% (+999 Thousand shares)
Q2 2020
Avg closing price
$35.88
Price range
$26.40
-
$45.30
Increased shares by 61.6% (+245 Thousand shares)
Q1 2020
Avg closing price
$26.88
Price range
$19.71
-
$35.15
New holding (+399 Thousand shares)
Q4 2019
Avg closing price
$23.40
Price range
$21.00
-
$26.48
